HC Wainwright & Co. analyst Douglas Tsao reiterates Alkermes (NASDAQ:ALKS) with a Neutral and maintains $32 price target.
What’s Going On With Kazia Therapeutics Stock Today?
Kazia Therapeutics Ltd (NASDAQ: KZIA) shares are trading higher Thursday after the company announced it received FDA Fast Track Designation for its